Cord Blood Preptin Levels in Infants
Comparison of Cord Blood Preptin Levels in Infants With Low and High Birth Weight for Gestational Age and Infants of Diabetic Mothers With Those of Normal Birth Weight Infants
1 other identifier
interventional
72
1 country
1
Brief Summary
In this study, cord blood preptin levels in infants with high or low birth weight will be compared to those in infants with normal birth weight. Our aim is to determine whether there is a relationship between birth weight and preptin levels. Additionally, we plan to compare the cord blood preptin levels of infants of diabetic mothers with those of normal birth weight infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2025
CompletedFirst Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedMarch 27, 2026
March 1, 2025
8 months
March 11, 2025
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum preptin level
The primary outcome variable is the comparison of serum preptin levels between large-for-gestational-age infants and infants of diabetic mothers with those of normal birth weight infants.The other variable is the comparison of serum preptin levels in small-for-gestational-age infants based on gestational age.
postnatal 5 minutes
Study Arms (4)
Appropriate for gestational age
EXPERIMENTALDuring delivery, blood samples will be collected from the umbilical cord of pregnant women who agree to participate in the study.
small for gestational age
EXPERIMENTALDuring delivery, blood samples will be collected from the umbilical cord of pregnant women who agree to participate in the study.
large for gestational age
EXPERIMENTALDuring delivery, blood samples will be collected from the umbilical cord of pregnant women who agree to participate in the study.
Baby of mother diagnosed with GDM
EXPERIMENTALDuring delivery, blood samples will be collected from the umbilical cord of pregnant women who agree to participate in the study.
Interventions
During delivery, blood samples will be collected from the umbilical cord of pregnant women who agree to participate in the study.
Eligibility Criteria
You may qualify if:
- Large-for-Gestational-Age (LGA) Infants
- Appropriate-for-Gestational-Age (AGA) Infants
- Small-for-Gestational-Age (SGA) Infants
- Infants of Diabetic Mothers (IDM)
You may not qualify if:
- Infants with a syndromic appearance or any accompanying disease
- Infants whose families did not provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Melek Buyukeren
Konya, Karatay, 42020, Turkey (Türkiye)
Related Publications (8)
Ungureanu MC, Bilha SC, Hogas M, Velicescu C, Leustean L, Teodoriu LC, Preda C. Preptin: A New Bone Metabolic Parameter? Metabolites. 2023 Sep 4;13(9):991. doi: 10.3390/metabo13090991.
PMID: 37755271BACKGROUNDAydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014 Jun;56:94-110. doi: 10.1016/j.peptides.2014.03.021. Epub 2014 Apr 8.
PMID: 24721335BACKGROUNDBuchanan CM, Phillips AR, Cooper GJ. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J. 2001 Dec 1;360(Pt 2):431-9. doi: 10.1042/0264-6021:3600431.
PMID: 11716772BACKGROUNDCheng KC, Li YX, Asakawa A, Ushikai M, Kato I, Sato Y, Cheng JT, Inui A. Characterization of preptin-induced insulin secretion in pancreatic beta-cells. J Endocrinol. 2012 Oct;215(1):43-9. doi: 10.1530/JOE-12-0176. Epub 2012 Jul 11.
PMID: 22787110BACKGROUNDYang G, Li L, Chen W, Liu H, Boden G, Li K. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Ann Med. 2009;41(1):52-6. doi: 10.1080/07853890802244142.
PMID: 18618352BACKGROUNDCelik O, Celik N, Hascalik S, Sahin I, Aydin S, Ozerol E. An appraisal of serum preptin levels in PCOS. Fertil Steril. 2011 Jan;95(1):314-6. doi: 10.1016/j.fertnstert.2010.08.058.
PMID: 20883990BACKGROUNDAslan M, Celik O, Karsavuran N, Celik N, Dogan DG, Botan E, Kafkasli A. Maternal serum and cord blood preptin levels in gestational diabetes mellitus. J Perinatol. 2011 May;31(5):350-5. doi: 10.1038/jp.2010.125. Epub 2010 Dec 16.
PMID: 21164426BACKGROUNDKirac UI, Demir E, Ozkan H, Sahtiyanci B, Uzun H, Ekinci I, Buyukkaba M, Durmus S, Akarsu M, Gelisgen R, Tabak O. Maternal serum preptin levels in the pathogenesis and diagnosis of Gestational diabetes mellitus. J Med Biochem. 2023 Mar 15;42(2):311-317. doi: 10.5937/jomb0-36287.
PMID: 36987416BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
MELEK BUYUKEREN
Konya City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 17, 2025
Study Start
March 10, 2025
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
March 27, 2026
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Once the study is published as a scientific article, it can be shared.